Current studies suggest that peripherally administered GLP-1RA has low concentrations in the cerebrospinal fluid, and higher doses or improved delivery systems (e.g., nanoparticles, liposome encapsulation) may be needed to increase brain exposure
Pancreatitis on Ozempic (semaglutide 0.5-2 mg): Incidence, Severity, and Realistic Expectations Pancreatitis on Ozempic (semaglutide 0.5-2 mg): Incidence, Severity, and Realistic Expectations At a glance Incidence in trials: ~0.3% (semaglutide) vs ~0.2% (comparators) across SUSTAIN 1-10 Typical onset: Weeks to months after initiation or dose escalation Severity distribution: Majority mild-to-moderate (Revised Atlanta Classification Grade A/B)
Liu J, Sun Y, Cheng M, Liu Q, Liu W, Gao C, et al
By supporting normal cellular processes, the peptide may help maintain overall vitality as the body ages naturally
According to the physicians surveyed, the main challenge when it comes to prescribing GLP-1RA drugs is insurance coverage issues
I discuss the vagus nerve and its role in dopamine and serotonin release in the brain
